Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 8, 1998, Pages 1615-1630

  Yue, Ping ^b   Long, Carlin S ^a,b,c   Austin, Richard ^b   Chang, Kevin C ^d   Simpson, Paul C ^a,b,c   Massie, Barry M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

Gene expression; Heart failure; Hypertrophy; Myocardial infarction; Rat

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; CONTRACTILE PROTEIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; PHOSPHOLAMBAN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; GENE EXPRESSION; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE CELL; IMMEDIATE EARLY GENE; IMMUNOBLOTTING; MALE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; TRANSCRIPTION REGULATION;

EID: 0032144054     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0727     Document Type: Article

References (48)

1. ANVERSA P, SONNENBLICK EH, 1990. Ischemic cardiomyopathy: Pathophysiologic mechanisms. Prog Cardiovasc Dis 33: 49-70.
2. ARAI M, ALPERT NR, MACLENNAN DH, BARTON P, PERIASAMY M, 1993. Alterations in sarcoplasmic reticulum gene expression in human heart failure. Circulation Res 72: 463-469.
3. ARAI M, MATSUI H, PERIASAMY M, 1994. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circulation Res 74: 555-564.
4. ARAI M, SUZUKI T, NAGAI R, 1996. Sarcoplasmic reticulum genes are upregulated in mild cardiac hypertrophy but downregulated in severe cardiac hypertrophy induced by pressure overload. J Mol Cell Cardiol 28: 1583-1590.
5. BRADFORD MM, 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Analytic Biochem 72: 248-254.
6. CALDERONE A, TAKAHASHI N, IZZO NJ, THAIK CM, COLUCCI WS, 1995. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 92: 2385-2390.
7. CAMPICI J, GRAY HE, PARDEE AB, DEAN M, 1984. Cell-cycle control. Cell 36: 24147.
8. 2+ handling is an early manifestation of pressure-overload hypertrophy. Am J Physiol 271: H228-H234.
9. CHASSAGNE C, WISNEWSKY C, SCHWARTZ K, 1993. Antithetical accumulation of myosin heavy chain but not α-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. Circulation Res 72: 857-864.
10. CHIEN K, KNOWLTON RK, ZHU H, CHIEN S, 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5: 3037-3046.
11. CHOMCZYNSKI P, SACCHI N, 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochem 162: 156-159.
12. 2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circulation Res 66: 554-564.
13. FELDMAN AM, WEINBERG EO, RAY PE, LORELL BH, 1993. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circulation Res 73: 184-192.
14. HANATANI A, YOSHIYAMA M, KIM S, OMURA T, TODA I, AKIOKA K, TERAGAKI M, TAKEUCHI K, IWAO H, TAKEDA T, 1995. Inhibition by angiotensin II type I receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 27: 1905-1914.
15. IZUMO S, LOMPRÉ A-M, MATSUOKA R, KOREN G, SCHWARTZ K, NADAL-GINARD B, MAHDAVI V, 1987. Myosin heavy chain Messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest 79: 970-977.
16. IZUMO S, NADAL-GINARD B, MAHDAVI V, 1988. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339-343.
17. 2+-ATPase protein levels. Circulation Res 77: 759-764.
18. KOMURO I, YAZAKI Y, 1993. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 55: 55-75.
19. KOMURO I, KAIDA T, SHIBAZAKI Y, KURIBAYASHI M, KATOH Y, HOH E, TAKAKO F, YAZAKI Y, 1990. Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem 265: 3595-3598.
20. LEVY AP, LEVY NS, LOSCALZO J, CALDERONE A, TAKAHASHI N, YEO K-T, KOREN G, COLUCCI WS, GOLDBERG MA, 1995. Regulation of vascular endothelial growth factor in cardiac myocytes. Circulation Res 76: 758-766.
21. LONG CS, 1996. Autocrine and paracrine regulation of myocardial cell growth in vitro. The TGFβ paradigm. Tr Cardiovasc Med 6: 217-226.
22. LYTTON J, WESTLIN M, BURK SE, SHULL GE, MACLENNAN DH, 1992. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J Biol Chem 267: 14483-14489.
23. MALLET F, ORIOL G, MARY C, VERRIER B, MANDRAND B, 1995. Continuous RT-PCR using AMV-RT and Taq DNA polymerase: characterization and comparison to uncoupled procedures. Bio Techniques 18: 678-687.
24. MASSIE BM, SHAH NB, 1997. Evolving trends in the epidemiology of heart failure: the rationale for preventive strategies and comprehensive disease management. Am Heart J 133: 703-712.
25. MEGGS LG, TILLOTSON J, HUANG H, SONNENBLICK EH, CAPASSO JM, ANVERSA P, 1990. Non-coordinate regulation of alpha-1 adrenoreceptor coupling and reexpression of alpha skeletal actin in myocardial infarction-induced left ventricular failure in rats. J Clin Invest 86: 1451-1458.
26. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85: 305-309.
27. 2+-ATPase and phospholamban mRNAs during rat heart development. Circulation Res 76: 616-625.
28. 2+-ATPase. Mechanism of regulation and site of monoclonal antibody interaction. J Biol Chem 266: 11270-11275.
29. 2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA 86: 2966-2970.
30. PERREAULT CL, WILLIAMS CP, MORGAN JP, 1993. Cytoplasmic calcium modulation and systolic versus diastolic dysfunction in myocardial hypertrophy and failure. Circulation 87: VII-31-VII-37.
31. PETROU M, WYNNE DG, BOHELER KR, YACOUB MH, 1995. Clembuterol induced hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation 92: II-483-II-489.
32. PFEFFER MA, BRAUNWALD E, 1990. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 81: 1161-1172.
33. PFEFFER MA, PFEFFER JM, FISHBEIN MC, FLETCHER PJ, SPADARO J, KLONER RA, BRAUNWALD E. 1979. Myocardial infarct size and ventricular function in rats. Circulation Res 44: 503-512.
34. REISS K, CAPASSO JM, HUANG H-E, MEGGS J-G, LI P, ANVERSA P, 1993. ANG II receptors c-myc and c-jun in myocytes afer myocardial infarction and ventricular failure. Am J Physiol 264: H760-H769.
35. 2+-ATPase in the rat heart. J Biol Chem 263: 6941-6944.
36. SADOSHIMA J, IZUMO S, 1993. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circulation Res 73: 413-423.
37. SCHNEIDER MD, PAYNE PA, UENO H, PERRYMAN MB, ROBERTS R, 1986. Dissociated expression of c-myc and a fos-related competence gene during cardiac myogenesis. Mol Cell Biol 6: 4140-4143.
38. SCHNEIDER MD, MCCLELLAN WR, BLACK FM, PARKER TG, 1992. Growth factors growth factor response elements and the cardiac phenotype. Basic Res Cardiol 87 (Suppl 2): 33-48.
39. SCHWARTZ K, DE LA BASTIE D, BOUVERET P, ALONSO S, BUCKINGHAM ME, 1986. α-skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circulation Res 59: 551-555.
40. SCHWARTZ K, CARRIER L, MERCADIER J, LOMPRÉ A, BOHELER KR, 1993. Molecular phenotype of the hypertrophied and failing myocardium. Circulation 87: VII-5-VII-10.
41. SHANI RZM, GIVOL D, NEUMAN S, YAFFE DN, NUDEL U, 1982. Nucleotide sequence of the rat skeletal muscle actin gene. Nature 298: 857-859.
42. SIMPSON PC, 1988. Proto-oncogenes and cardiac hypertrophy. Annu Rev Physiol 51: 189-202.
43. SMITH SH, KRAMER MF, REIS I, BISHOP SP, INGWALL JS, 1990. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circulation Res 67: 1334-1344.
44. 1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts. Circulation Res 75: 796-802.
45. TAKAHASHI T, SCHYBKKERT H, ISOYAMA S, 1992. Age-related differences in the expression of proto-oncogenes and contractile protein genes in response in the rat myocardium. J Clin Invest 89: 939-946.
46. TRAVALI S, KONIECKI J, PETRALLA S, BASERGA R, 1990. Oncogenes in growth and development. FASEB J 4: 3209-3214.
47. 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J Clin Invest 85: 1204-1214.
48. YAMANAKA M, GREENBERG B, JOHNSON L, SEILHAMER J, BREWER M, FRIEDEMANN T, MILLER J, ATLAS S, LARAGH J, LEWICKI J, FIDDES J, 1984. Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor. Nature 309: 719-722.